This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations and address vaccine hesitancy to improve access by using a proactive organized population-based outreach leveraging health information technology with tailored navigation support to address mistrust and social barriers.
This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations through a proactive organized population-based outreach approach. It will leverage health information technology with tailored navigation support to address mistrust and social barriers. Study key objectives are to: 1. conduct a survey of patients to assess and track barriers, intent, and sources of information on COVID vaccine over time. 2. Determine whether a primary care physician (PCP) endorsement with or without interactive digital communication plus navigation is more effective in promoting uptake of COVID-19 vaccine than general messages from the clinic. Patients will be randomized to one of three arms: 1. Arm 1: Message about vaccine availability delivered by SMS advising patients to make an appointment. 2. Arm 2: Same as Arm 1 but delivered as a personalized message text from the PCP. 3. Arm 3: Same as Arm 2 plus a interactive 2-way SMS options.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
1,722
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. Links to information or phone for scheduling will be provided. Messages mimic the clinic's usual practice of information delivery to patients
Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. The SMS message is personalized as a recommendation from the primary care clinician
This intervention is same as in the Arm 2 using personalized messaging from the PCP. In addition, patients are given interactive or 2-way SMS options to obtain additional information about COVID vaccine and answers to frequently asked questions.
Mayo Clinic
Scottsdale, Arizona, United States
Dose 1 COVID-19 Vaccine
Primary outcome will be the receipt of the first dose of any of the COVID-19 vaccines with FDA emergency use authorization
Time frame: 30 days
Dose 2 COVID-19 Vaccine
Examine receipt of all doses as recommended by the manufacturer (for most vaccine2 doses).
Time frame: 60 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.